| Factor Information | |
|---|---|
| Data ID | 1423 |
| Factor | right ventricular assist device(RVAD) |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | 30-day and 1-year mortality. |
| p Value | <0.001 |
| Conclusion | The need for RVAD implantation was identified as a significant periprocedural risk factor for 30-day and 1-year mortality. |
| Risk Factor | risk factor (article mentioned) |
| CHD Type | |
|---|---|
| ID | 528 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | DORV, VSD/TOF/TGA/DOLV, PS/DILV, TGA, PS/ALVT/EA/DILV, VSD, PS/DORV, TGA, VSD, PS/ccTGA/VSD, CoA, PLSVC/PA, VSD/TGA, VSD/DORV, VSD, ASD, PS |
| Reference | |
|---|---|
| PMID | 26857637 |
| Year | 2017 |
| Title | Non-Fontan Adult Congenital Heart Disease Transplantation Survival Is Equivalent to Acquired Heart Disease Transplantation Survival. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | Prague, Czech | |
| Method | Fisher exact test | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | medical treatment , heart transplantation | |
| Group | CHD patients(Treatment) | CHD patients(Control) |
| Number | 25(CHD patients) | 25(CHD patients) |
| Age | 38 years(18.4-53.7 years) | 38 years(18.4-53.7 years) |
| Gender (Male: Female) | 17:8 | 17:8 |
| Marker Level | N/A | N/A |
